Filing Details

Accession Number:
0001104659-12-025725
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-16 19:00:59
Reporting Period:
2012-04-13
Filing Date:
2012-04-16
Accepted Time:
2012-04-16 18:00:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1213037 Trovagene Inc. TROV Biological Products, (No Disgnostic Substances) (2836) 043721895
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1253803 Gabriel Cerrone C/O Synergy Pharmaceuticals, Inc.
420 Lexington Avenue, Suite 1609
New York NY 10170
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-13 200,000 $0.50 3,940,356 No 4 P Indirect By Panetta Partners Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Panetta Partners Ltd.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2012-04-13 200,000 $0.00 200,000 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,184,498 2012-04-13 2018-12-31 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 37,500 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrants $0.50 2011-01-06 2018-12-31 37,500 37,500 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-12-31 37,500 37,500 Direct
Footnotes
  1. Mr. Cerrone is the sole managing partner of Panetta Partners, Ltd. and in such capacity exercises voting and dispositive control over securities owned by Panetta despite him having only a small pecuniary interest in such securities.